OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
Philip Ridley-Smith is the business development and marketing manager at RecipharmCobra Biologics
The pathway for biosimilar approval in the US has been set. But are US patients too far behind Europe?